MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
Jiaofeng Huang,1,* Wenjuan Xue,2,* Mingfang Wang,1 Yinlian Wu,1 Medha Singh,3 Yueyong Zhu,1,4 Rahul Kumar,5 Su Lin1 1Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, People’s Republic of China;...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d35b26b12fbc41f3b38e6c86900e9672 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|